WAIVER AND AMENDMENT No. 1 to the Capital Protection Agreement
Exhibit (h)(156)
This amendment and waiver (the “Waiver and Amendment”) is made as of November 8, 2012,
among BNP Paribas Prime Brokerage Inc. (the “Capital Protection Provider” and
“Agent”), and Janus Investment Fund (the “Trust”), on behalf of its series, Janus
Protected Series – Global (the “Fund”).
WHEREAS, the Trust, the Fund, the Agent, Janus Capital Management LLC and BNP Paribas are
parties to a Capital Protection Agreement dated as of December 15, 2011 (the “Capital
Protection Agreement;” undefined capitalized terms used herein shall have the meanings assigned
thereto in the Capital Protection Agreement);
WHEREAS, pursuant to Section 5.01(i) of the Capital Protection Agreement, if the Fund is
required to post collateral to any counterparty pursuant to a Derivatives Transaction, the Fund is
required to have the collateral held for the benefit of the counterparty in an account of the Fund
maintained with a third-party bank, securities intermediary or trust company which (i) is
unaffiliated to such counterparty and (ii) has assets of at least $10 billion and a long-term debt
rating or deposit rating of not less than “A” from S&P or “A2” from Moody’s;
WHEREAS, prior to the date hereof, the Fund posted margin for futures directly with Xxxxxxx,
Sachs & Co. (or any Affiliate thereof) and did not have the collateral held in a third-party bank,
securities intermediary or trust company in compliance with Section 5.01(i) of the Capital
Protection Agreement (each such direct posting of margin being a “Specified Transactions”);
WHEREAS, pursuant to Section 5.01(b) and subsection (xii) of Schedule II of the Capital
Protection Agreement, the Fund is required to deliver certain reports (the “Relevant
Reports”) to the Capital Protection Provider on or before 3:00 a.m., 9:45 a.m. and 2:00 p.m.
New York City time (the “Applicable Deadlines”);
WHEREAS, prior to the date hereof, the Fund from time to time delivered the Relevant Reports
after the Applicable Deadlines (the “Specified Reporting Delays”);
WHEREAS, the Fund has requested that (a) the Capital Protection Provider waive any
non-compliance by the Fund with Section 5.01(i) prior to the date hereof with respect to the
Specified Transactions and to amend Section 5.01(i) to permit the Fund to post required margin for
futures directly with a futures commission merchant if, and to the extent that, applicable Law
requires such margin to be posted directly with such futures commission merchant, (b) the Capital
Protection Provider amend Section 5.01(i) to reduce the minimum credit ratings of banks and
securities intermediaries permitted to hold collateral posted by the Fund in connection with
Derivatives Transactions, and (c) the Capital Protection Provider waive any non-compliance by the
Fund with Section 5.01(b) and subsection (xii) of Schedule II prior to the date hereof with respect
to the Specified Reporting Delays and to amend subsection (xii) of Schedule II to permit the Fund
to deliver the Relevant Reports by 3:30 a.m., 10:15 a.m. and 2:30 p.m. (New York City time);
WHEREAS, the Fund and the Capital Protection Provider also desire to replace Appendix C and
Appendix D to the Capital Protection Agreement with Appendix C and Appendix D to this Waiver and
Amendment, and the Fund has requested that Appendix A be amended to permit short futures based on
MSCI Emerging Markets Mini Index Futures to be Eligible Positions.
NOW, THEREFORE, in consideration of the premises set forth above, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Fund, the
Capital Protection Provider and the Agent agree as follows:
1. Amendments. Effective as of the date first above written and subject to the
execution of this Waiver and Amendment by the parties hereto, the Capital Protection Agreement is
hereby amended as follows:
(a) Definitions. Section 1.01 is hereby amended by adding the following definitions
in the appropriate alphabetical order:
“CEA” means the U.S. Commodity Exchange Act, as amended, and the rules and
regulations thereunder.
“FCM” means a “futures commission merchant” as defined in the CEA that is
registered with the Commodity Futures Trading Commission.
(b) Margin. Section 5.01(i) is hereby amended and restated as follows:
“(i) Margin. If the Fund is required to post collateral to, or receive
collateral from, any counterparty pursuant to a Derivatives Transaction, the Fund shall
ensure that such collateral is held for the benefit of the counterparty in an account of the
Fund maintained with a third-party bank, securities intermediary or trust company which (i)
is unaffiliated to such counterparty and (ii) has assets of at least $10 billion and a long
term debt rating of not less than “A-”, if rated by S&P, or “A3”, if rated by Moody’s;
provided, that the Fund may post required margin for futures transactions directly
with the counterparty if the counterparty is a FCM and applicable Law requires such margin
to be posted directly with such FCM.”
(c) Schedule II. Subsection (xii) of Schedule II is hereby amended to replace “3:00
a.m.” with “3:30 a.m.”, “9:45 a.m.” with “10:15 a.m.”, and “2:00 p.m.” with “2:30 p.m.”.
(d) Appendix A. The fifth (5th) criteria for Eligible Positions under the
heading “Eligibility Criteria” in Appendix A is hereby amended to add the words “or the MSCI
Emerging Markets Mini Index” immediately after the words “the MSCI Emerging Markets Index” in the
first line thereof. The definition of “Eligible Index” is hereby amended to add the words “and the
MSCI Emerging Markets Mini Index.” immediately after the words “the MSCI Emerging Markets Index”.
(e) Appendix C and Appendix D. Appendix C and Appendix D are hereby amended and
restated in their entirety with Appendix C and Appendix D attached hereto.
2
2. Waiver. Effective as of the date first written above and subject to the execution
of this Waiver and Amendment by the parties hereto, the Capital Protection Provider hereby waives
(a) any non-compliance of Section 5.01(i) prior to the date hereof with respect to Specified
Transaction to the extent the Specified Transactions were in compliance with the proviso to Section
5.01(i) as amended by this Waiver and Amendment, and (b) any non-compliance of Section 5.01(b) and
subsection (xii) of Schedule II prior to the date hereof with respect to any Specified Reporting
Delays.
3. Representations. Each party hereto makes, as of the date of this Waiver and
Amendment, all representations set forth below:
(a) Each party hereto has all requisite power and authority to execute and deliver this Waiver
and Amendment, and this Waiver and Amendment has been duly authorized, executed an delivered by
each such party hereto and is enforceable against such party in accordance with its terms; and
(b) Any authorization, approval, consent, waiver or other action by, notice to, or filing,
qualification or declaration with, any governmental or regulatory authority or body or other person
required for the due execution, delivery or performance of this Waiver and Amendment by each party
has been duly obtained or made and is in full force and effect.
4. Reference to and Effect on the Capital Protection Agreement
(a) Upon the effectiveness of Section 1 hereof, each reference in the Capital
Protection Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import
shall mean and be a reference to the Capital Protection Agreement as amended and modified hereby,
and each reference to the Capital Protection Agreement in any other document, instrument or
agreement shall mean and be a reference to the Capital Protection Agreement as modified hereby.
(b) The Capital Protection Agreement, as amended hereby, and all other documents, instruments
and agreements executed and/or delivered in connection therewith, shall remain in full force and
effect, and are hereby ratified and confirmed.
(c) Except as expressly provided herein, the execution, delivery and effectiveness of this
Waiver and Amendment shall not operate as a waiver of any right, power or remedy of the Capital
Protection Provider or the Agent, nor constitute a waiver of any provision of the Capital
Protection Agreement or any other documents, instruments and agreements executed and/or delivered
in connection therewith.
5. GOVERNING LAW. THIS WAIVER AND AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE OTHER REMAINING TERMS OF THE CAPITAL PROTECTION AGREEMENT AND THE INTERNAL LAWS
(AS OPPOSED TO CONFLICT OF LAW PROVISIONS) OF THE STATE OF NEW YORK.
3
6. Paragraph Headings. The paragraph headings contained in this Waiver and Amendment
are and shall be without substance, meaning or content of any kind whatsoever and are not a part of
the agreement among the parties hereto.
7. Counterparts. This Waiver and Amendment may be executed in one or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument.
4
IN WITNESS WHEREOF, the parties hereto have caused this Waiver and Amendment to be executed
and delivered by their respective authorized officers as of the date appearing in the first
paragraph above.
| JANUS INVESTMENT FUND, on behalf of its series, Janus Protected Series — Global |
|||||
| By: | /s/ Xxxxxxxxx Xxxxxxxxxx-Xxxxxx | ||||
| Name: | Xxxxxxxxx Xxxxxxxxxx-Xxxxxx | ||||
| Title: | Vice President | ||||
| BNP PARIBAS PRIME BROKERAGE INC., as Capital Protection Provider and Agent |
|||||
| By: | /s/ Xxxxxxx Xxxx | ||||
| Name: | Xxxxxxx Xxxx | ||||
| Title: | Managing Director | ||||
| By: | /s/ Raphael Masgnaux | ||||
| Name: | Raphael Masgnaux | ||||
| Title: | Managing Director | ||||
5
